BARR CONFIRMS SAVIENT PATENT CHALLENGE

Barr Pharmaceuticals Inc. confirmed Wednesday it is challenging the patents protecting Savient Pharmaceuticals Inc.'s Oxandrin CIII weight gain treatment.

MSN Money (http://news.moneycentral.msn.com/provider/providerarticle.asp?feed=AP&Date=20060927&ID=6057244)